Curiox Biosystems Co., Ltd (KOSDAQ:445680)

South Korea · Delayed Price · Currency is KRW

63,200

+9,200 (17.04%)

At close: Oct 21, 2026

Market Cap	1.09T -8.6%
Revenue (ttm)	5.73B +49.9%
Net Income	-12.78B
EPS	-750.57
Shares Out	17.20M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	254,730
Open	55,400
Previous Close	54,000
Day's Range	55,000 - 64,100
52-Week Range	31,650 - 149,200
Beta	2.07
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 13, 2026

About Curiox Biosystems

Curiox Biosystems Co., Ltd manufactures and sells automated equipment and consumables for cell analysis processes in South Korea. It offers C-FREE Pluto systems, including Pluto workstation, an Automated Antibody Cocktailing and Cell Staining in One Station; Pluto ALPHA, a Centrifuge-free cell washing; Pluto Code, a software script that brings Curiox’s centrifuge-free washing technology. The company offers other products & accessories, including C-FREE Gripper, C-FREE Tilter, DropArray Station, DropArray Bead Plates, MINI 1000 System, HT2100 Sy... [Read more]

Industry Surgical and Medical Instruments and Apparatus

Founded 2018

Employees 26

Stock Exchange KOSDAQ

Ticker Symbol 445680

Full Company Profile

Financial Performance

In 2025, Curiox Biosystems's revenue was 5.15 billion, an increase of 12.29% compared to the previous year's 4.59 billion. Losses were -27.18 billion, 236.0% more than in 2024.

Financial Statements